Stem cell therapy: proffering hope for special needs patientsBusinessDay (satire) (press release) (registration) (blog)Hope is surely on the way for children with special needs as Alok Sharma, a world renowned neurosurgeon, Neuroscientist and professor… Continue reading
BusinessDay (satire) (press release) (registration) (blog)Stem cell therapy: proffering hope for special needs patientsBusinessDay (satire) (press release) (registration) (blog)Hope is surely on the way for children with special needs as Alok Sharma, a… Continue reading
BusinessDay (satire) (press release) (registration) (blog)Stem cell therapy: proffering hope for special needs patientsBusinessDay (satire) (press release) (registration) (blog)Hope is surely on the way for children with special needs as Alok Sharma, a… Continue reading
BusinessDay (satire) (press release) (registration) (blog)Stem cell therapy: proffering hope for special needs patientsBusinessDay (satire) (press release) (registration) (blog)Hope is surely on the way for children with special needs as Alok Sharma, a… Continue reading
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
Boing Boing |
The promise and peril of synthetic biology in 78 minutes
Boing Boing The upside and the downside of synthetic biology are vast and Andy is deeply versed in both. He co-wrote a chilling fictive scenario about a bioterror plot for the Atlantic – but he tends toward relentless optimism when contemplating synthetic biology … |
UC San Diego Health |
State’s Stem Cell Agency Awards $18.2 Million Grant for B Cell Cancer Clinical Trial
UC San Diego Health The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) today unanimously approved an $18.29 million grant to University of California San Diego School of Medicine researchers to fund a phase Ib/IIa … |